These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31519470)

  • 1. Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping.
    Deborde E; Dubourg B; Bejar S; Brehin AC; Normant S; Michelin P; Dacher JN
    Diagn Interv Imaging; 2020 Feb; 101(2):59-67. PubMed ID: 31519470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.
    Karur GR; Robison S; Iwanochko RM; Morel CF; Crean AM; Thavendiranathan P; Nguyen ET; Mathur S; Wasim S; Hanneman K
    Radiology; 2018 Aug; 288(2):398-406. PubMed ID: 29688154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Cardiac Involvement in Fabry Disease (FD) with Native T1 Mapping.
    Roller FC; Fuest S; Meyer M; Harth S; Gündüz D; Bauer P; Schneider C; Rolfs A; Krombach GA; Tanislav C
    Rofo; 2019 Oct; 191(10):932-939. PubMed ID: 30754056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.
    Kozor R; Nordin S; Treibel TA; Rosmini S; Castelletti S; Fontana M; Captur G; Baig S; Steeds RP; Hughes D; Manisty C; Grieve SM; Figtree GA; Moon JC
    Eur Heart J Cardiovasc Imaging; 2017 Sep; 18(9):1034-1040. PubMed ID: 27590835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
    Pica S; Sado DM; Maestrini V; Fontana M; White SK; Treibel T; Captur G; Anderson S; Piechnik SK; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Kellman P; Elliott PM; Herrey AS; Moon JC
    J Cardiovasc Magn Reson; 2014 Dec; 16(1):99. PubMed ID: 25475749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.
    Antezana-Chavez E; Cianciulli TF; Hadid CL; Toro DD; Celano L; Saccheri MC; Baez KG; Lopez CA; Labadet CD; Gagliardi JA
    Am J Cardiol; 2022 Sep; 178():131-136. PubMed ID: 35810008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
    Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
    Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping.
    Walter TC; Knobloch G; Canaan-Kuehl S; Greiser A; Sandek A; Blaschke D; Denecke T; Hamm B; Makowski MR
    Acta Radiol; 2017 Aug; 58(8):914-921. PubMed ID: 27799574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram Analysis of Native T
    Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
    J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
    Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy.
    Lavall D; Vosshage NH; Geßner R; Stöbe S; Ebel S; Denecke T; Hagendorff A; Laufs U
    Clin Res Cardiol; 2023 Mar; 112(3):334-342. PubMed ID: 35355115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
    Sado DM; White SK; Piechnik SK; Banypersad SM; Treibel T; Captur G; Fontana M; Maestrini V; Flett AS; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Neubauer S; Elliott PM; Moon JC
    Circ Cardiovasc Imaging; 2013 May; 6(3):392-8. PubMed ID: 23564562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 mapping using saturation recovery single-shot acquisition at 3-tesla magnetic resonance imaging in hypertrophic cardiomyopathy: comparison to late gadolinium enhancement.
    Ogawa R; Kido T; Nakamura M; Kido T; Kurata A; Uetani T; Ogimoto A; Miyagawa M; Mochizuki T
    Jpn J Radiol; 2017 Mar; 35(3):116-125. PubMed ID: 28105599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Phenotype of Prehypertrophic Fabry Disease.
    Nordin S; Kozor R; Baig S; Abdel-Gadir A; Medina-Menacho K; Rosmini S; Captur G; Tchan M; Geberhiwot T; Murphy E; Lachmann R; Ramaswami U; Edwards NC; Hughes D; Steeds RP; Moon JC
    Circ Cardiovasc Imaging; 2018 Jun; 11(6):e007168. PubMed ID: 29853467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomic Analysis of Native T
    Wang J; Yang F; Liu W; Sun J; Han Y; Li D; Gkoutos GV; Zhu Y; Chen Y
    J Magn Reson Imaging; 2020 Dec; 52(6):1714-1721. PubMed ID: 32525266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
    Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
    Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.